Nanoparticles for cancer therapy: current progress and challenges

S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …

Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy

M Mahmoudi, S Sant, B Wang, S Laurent… - Advanced drug delivery …, 2011 - Elsevier
At present, nanoparticles are used for various biomedical applications where they facilitate
laboratory diagnostics and therapeutics. More specifically for drug delivery purposes, the …

Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer

S Palanisamy, YM Wang - Dalton transactions, 2019 - pubs.rsc.org
Cancer is a global epidemic and is considered a leading cause of death. Various cancer
treatments such as chemotherapy, surgery, and radiotherapy are available for the cure but …

Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type

K Kettler, K Veltman, D van De Meent… - Environmental …, 2014 - Wiley Online Library
The increased application of nanoparticles (NPs) is increasing the risk of their release into
the environment. Although many toxicity studies have been conducted, the environmental …

[HTML][HTML] Nanoparticles: Emerging carriers for drug delivery

SR Mudshinge, AB Deore, S Patil… - Saudi pharmaceutical …, 2011 - Elsevier
The core objective of nanoparticles is to control and manipulate biomacromolecular
constructs and supramolecular assemblies that are critical to living cells in order to improve …

Nanoparticles in cancer treatment: opportunities and obstacles

R Awasthi, A Roseblade, PM Hansbro… - Current drug …, 2018 - ingentaconnect.com
In the United States, the estimated number of new cancer cases in 2018 will be approx. 1.7
million. Historically, combination chemotherapy has been the primary choice of treatment …

[PDF][PDF] RETRACTED ARTICLE: Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress

S Naqvi, M Samim, MZ Abdin, FJ Ahmed… - International journal …, 2010 - Taylor & Francis
Naqvi S, Samim M, Abdin M, et al. Int J Nanomedicine. 2010; 5: 983–989. The Editor and
Publisher of the International Journal of Nanomedicine wish to retract the published article …

Cancer theranostics: the rise of targeted magnetic nanoparticles

AJ Cole, VC Yang, AE David - Trends in biotechnology, 2011 - cell.com
Interest in utilizing magnetic nanoparticles (MNP) for biomedical applications has increased
considerably over the past two decades. This excitement has been driven in large part by …

Magnetic nanoparticles: a novel platform for cancer theranostics

A Singh, SK Sahoo - Drug discovery today, 2014 - Elsevier
Highlights•MNPs act as theranostic agents because of intrinsic magnetic properties.•MNPs
act as a diagnostic tool by acting as contrast agents for MRI.•MNPs can deliver drugs or …

Stabilization and functionalization of iron oxide nanoparticles for biomedical applications

E Amstad, M Textor, E Reimhult - Nanoscale, 2011 - pubs.rsc.org
Superparamagnetic iron oxide nanoparticles (NPs) are used in a rapidly expanding number
of research and practical applications in the biomedical field, including magnetic cell …